Exelixis
EXEL
#1785
Rank
S$15.33 B
Marketcap
S$57.18
Share price
2.57%
Change (1 day)
15.30%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2024: S$0.86 Billion

According to Exelixis's latest financial reports the company's current earnings are S$2.28 Billion. In 2024 the company made an earning of S$0.86 Billion, an increase over its 2023 earnings that were of S$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2024

Annual earnings

Year Earnings Change
2024S$0.86 B164.69%
2023S$0.32 B9.89%
2022S$0.29 B-20.33%
2021S$0.37 B124.82%
2020S$0.16 B-67.14%
2019S$0.50 B-11.94%
2018S$0.57 B185.09%
2017S$0.20 B-325.82%
2016-S$88.95 Million-58.12%
2015-S$0.22 Billion-37.61%
2014-S$0.35 Billion9.75%
2013-S$0.32 Billion65.96%
2012-S$0.19 Billion-291.63%
2011S$97.52 M-195.59%
2010-S$0.11 Billion-42.17%
2009-S$0.18 Billion-18.98%
2008-S$0.22 Billion-6.99%
2007-S$0.24 Billion46.3%
2006-S$0.17 Billion33.25%
2005-S$0.13 Billion-30.92%
2004-S$0.18 Billion44.29%
2003-S$0.13 Billion12.86%
2002-S$0.11 Billion22.79%
2001-S$86.95 Million60.14%
2000-S$54.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.03 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.01 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.44 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.52 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$29.24 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.17 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.80 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-S$41.25 Million-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-S$36.79 Million-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA